Skip to main content
. 2004 Sep 16;560(Pt 3):941–948. doi: 10.1113/jphysiol.2004.071779

Figure 1. Group mean (± s.e.m.) CVC data from protocol 1.

Figure 1

Values are from the plateau in skin blood flow during whole body heating. Compared with control, pyrilamine significantly reduced CVC. Similarly, l-NAME significantly reduced CVC compared with control. l-NAME plus pyrilamine attenuated CVC compared with control and the pyrilamine only sites but was not significantly different from l-NAME only sites. *P < 0.001 versus control site; †P < 0.05 versus pyrilamine only site.